BioE seeks FDA approval for cord blood device

11/28/2007 | Star Tribune (Minneapolis-St. Paul, Minn.)

BioE has applied for FDA approval to market its PrepaCyte-CB system, a device used in collecting and separating stem cells from human umbilical cord blood. The device could help cord blood banks improve their processing techniques and protocols, a BioE executive said.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN